Business Description
hVIVO PLC
ISIN : GB00B9275X97
Description
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.85 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.34 | |||||
| Debt-to-EBITDA | 0.74 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.66 | |||||
| Beneish M-Score | -1.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.1 | |||||
| 3-Year FCF Growth Rate | 53.3 | |||||
| 3-Year Book Growth Rate | 14.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 12.42 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.48 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.98 | |||||
| 9-Day RSI | 25.22 | |||||
| 14-Day RSI | 31.03 | |||||
| 6-1 Month Momentum % | -12.26 | |||||
| 12-1 Month Momentum % | 13.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 1.03 | |||||
| Days Inventory | 5.04 | |||||
| Days Sales Outstanding | 52.39 | |||||
| Days Payable | 20.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.07 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| Forward Dividend Yield % | 1.07 | |||||
| 5-Year Yield-on-Cost % | 1.07 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -7.21 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.66 | |||||
| Operating Margin % | 20.72 | |||||
| Net Margin % | 27.1 | |||||
| FCF Margin % | 10.06 | |||||
| ROE % | 55.42 | |||||
| ROA % | 23.52 | |||||
| ROIC % | 30.65 | |||||
| ROC (Joel Greenblatt) % | 97.29 | |||||
| ROCE % | 34.99 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.58 | |||||
| Forward PE Ratio | 10.8 | |||||
| PE Ratio without NRI | 14.07 | |||||
| Price-to-Owner-Earnings | 6.16 | |||||
| PS Ratio | 2.1 | |||||
| PB Ratio | 3.46 | |||||
| Price-to-Tangible-Book | 4.32 | |||||
| Price-to-Free-Cash-Flow | 21.89 | |||||
| Price-to-Operating-Cash-Flow | 10.37 | |||||
| EV-to-EBIT | 7.68 | |||||
| EV-to-Forward-EBIT | 8.83 | |||||
| EV-to-EBITDA | 6.27 | |||||
| EV-to-Forward-EBITDA | 7 | |||||
| EV-to-Revenue | 1.71 | |||||
| EV-to-Forward-Revenue | 1.61 | |||||
| EV-to-FCF | 16.84 | |||||
| Price-to-Projected-FCF | 2.16 | |||||
| Price-to-Median-PS-Value | 1.44 | |||||
| Price-to-Graham-Number | 1.66 | |||||
| Price-to-Net-Current-Asset-Value | 21.6 | |||||
| Earnings Yield (Greenblatt) % | 13.02 | |||||
| FCF Yield % | 4.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
hVIVO PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 75.488 | ||
| EPS (TTM) (€) | 0.03 | ||
| Beta | 2.7 | ||
| Volatility % | 40.96 | ||
| 14-Day RSI | 31.03 | ||
| 14-Day ATR (€) | 0.007911 | ||
| 20-Day SMA (€) | 0.24 | ||
| 12-1 Month Momentum % | 13.33 | ||
| 52-Week Range (€) | 0.214 - 0.366 | ||
| Shares Outstanding (Mil) | 680.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
hVIVO PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
hVIVO PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
hVIVO PLC Frequently Asked Questions
What is hVIVO PLC(FRA:CRO)'s stock price today?
The current price of FRA:CRO is €0.22. The 52 week high of FRA:CRO is €0.37 and 52 week low is €0.21.
When is next earnings date of hVIVO PLC(FRA:CRO)?
The next earnings date of hVIVO PLC(FRA:CRO) is 2025-04-09 Est..
Does hVIVO PLC(FRA:CRO) pay dividends? If so, how much?
The Dividend Yield %  of hVIVO PLC(FRA:CRO) is 1.07% (As of Today), Highest Dividend Payout Ratio of hVIVO PLC(FRA:CRO) was 0.13. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of hVIVO PLC(FRA:CRO) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers